Introduction
Trigeminal neuralgia (TN) is a form of neuropathic pain characterized by severe lancinating pain in orofacial regions innervated by the trigeminal nerve. It is thought that most cases of TN result from compression of a trigeminal nerve root by the superior cerebellar artery in the posterior cranial fossa [1] [2] [3] . A significant proportion of TN patients report spontaneous pain in addition to the pain attacks [4, 5] . Treatment options currently available for TN fail to provide reliable and permanent pain relief in all patients. Studies that con-Multiple laboratories have proposed an imbalance of inhibitory and facilitatory input during chronic pain states with a net gain in descending pain facilitation [10] [11] [12] [13] . The rostral ventromedial medulla (RVM) is a critical site for descending modulation of nociceptive transmission [14] and has been implicated both in inhibition and facilitation of pain [15] . Preclinical models using spinal nerve injury indicate that the role of the RVM in pain modulation seems to change following nerve injury [12] . Spinal nerve injury induced evoked hypersensitivity has an initiation stage across approximately the first week during which evoked hypersensitivity is independent of descending facilitatory pathways from the RVM [12] . This is followed by a maintenance stage emerging during the second week during which evoked hypersensitivity is dependent on descending facilitation [12] . Subsequent studies demonstrated that descending facilitatory pain pathways from the RVM also mediate nerve-injury induced spontaneous pain [16, 17] . The role of descending projections from the RVM to maintain different aspects of trigeminal neuropathic pain has not been explored. The present study examined the hypothesis that RVM neurons mediates tactile hypersensitivity and spontaneous pain 15 days post-CCI-ION, but do not alter thermal hypersensitivity or spontaneous pain 5 days post-CCI-ION.
Material and methods

Animals
Conventional heterogenic adult male Wistar rats, an outbred rat strain, weighing 200-220 g were used. Animals were bred and housed by the animal care facility of UFPR. Rats were housed 5 per cage on wood shaver bedding, maintained in a climate-controlled room at 22 ± 2 • C on a 12-h light/dark cycle with laboratory chow and tap water ad libitum. Studies were performed during the light cycle between 7:00 a.m. and 7:00 p.m. All procedures were approved by UFPRís institutional Committee on the Ethical Use of Animals (authorization # 805) and performed in accordance with the recommendations of the International Association for Study of Pain [18] and Brazilian regulations on animal welfare. All efforts were made to improve welfare and minimize the number of animals used.
RVM cannulation
Bilateral cannulation of the RVM was performed as previously described [12] . Animals were anesthetized with ketamine/xylazine (90/10 mg/kg, respectively) and placed in a stereotaxic apparatus. The skull was exposed and two 26-gauge guide cannulas separated by 1.2 mm (Plastics One Inc, Roanoke, VA) were directed toward the lateral portions of the RVM (AP-11.0 mm from bregma, L ±0.6 mm, DV-8.5 mm from the base of skull). The guide cannulas were cemented in place and fixed by small stainless steel screws. Rats then received oxytetracyclin (480 mg/kg, i.m.) and were allowed to recover 7 days before any behavioral testing or surgery.
Chronic Constriction Injury of the Infraorbital Nerve -CCI-ION
One week after RVM cannulation, animals were subjected to CCI-ION or sham surgery with some modifications [19] of the method proposed by Vos et al. [8] . Rats were anesthetized with ketamine/xylazine (90/10 mg/kg, respectively). An incision was made in the skin of the snout, under the right eye, about 3 mm caudal to the mystacial pads to expose the rostral end of the infraorbital nerve as it emerged from the infraorbital fissure. Two silk 4-0 ligatures were tied loosely around the infraorbital nerve 2 mm apart.
The wound was closed with silk sutures. Sham operated rats were treated identically, but no ligatures were applied to the infraorbital nerve. After surgery, all rats were maintained in a warm room until they recovered from anesthesia. Independent groups of CCI-ION or sham rats were used for each behavioral test.
Evaluation of heat hypersensitivity
Heat sensory thresholds on the ipsilateral side of the face were measured before and 5 days post-surgery as previously described by Almeida et al. [20] , with some modifications [21] . Each animal was removed from its home cage and gently held by the experimenter. A radiant heat source maintained at 50 • C was positioned 1 cm from the surface of the right vibrissal pad. The latency to display either head withdrawal or vigorous flicking of the snout was recorded. A 20 s cut-off time was used to prevent tissue damage. To examine the effects of systemic administration of lidocaine, rats received lidocaine (10 mg/kg, s c.) or equivolume saline by a subcutaneous injection into the loose skin over the neck. Response latencies were assessed 30, 60, 90, 120, 150 and 180 min postinjection. To evaluate effects of RVM lidocaine injections, separate groups of rats received lidocaine (4% w/v in 0.5 l) or equivolume saline injections across 1 min through a 33-gauge injection cannula protruding an additional 1 mm into fresh brain tissue to prevent backflow of drug. Response latencies were assessed 30, 60, 90 and 120 min post-injection. Only the ipsilateral side of the face was tested in to avoid overstimulation of the animal during testing of the time-course of the lidocaine effects on heat hypersensitivity.
Evaluation of mechanical hypersensitivity
Facial mechanical hypersensitivity was assessed before and 15 days post-surgery. During each testing session, animals were habituated to individual cages (30 × 30 × 30 cm) for a minimum of 2 h as described [22] . Mechanical thresholds were measured using calibrated von Frey filaments ranging from 0.04 to 8 g. Each stimulation series began with the 0.4 g filament, applied 3 times near the center of the right vibrissal pad, and proceeded up to the filament that evoked one of the following nociceptive behaviors twice: brisk head withdrawal, escape or attack reactions or short-lasting facial grooming. Only rats that did not react to application of the 8 g filament at pre-surgery testing were used for subsequent testing. Systemic or intra RVM injections of lidocaine were performed in separate cohorts of rats as described above. Mechanical thresholds were assessed 30, 60, 90 and 120 min post-injection. Only the ipsilateral side of the face was tested in to avoid overstimulation of the animal during testing of the time-course of the lidocaine effects on mechanical hypersensitivity.
Conditioned place preference (CPP)
A single-trial conditioning procedure was performed as previously described [23] . CPP was performed either days 4-6 post-surgery or days 14-16 post-surgery. Separate groups of rats were used at each time-point.
On the first day (i.e. preconditioning), rats were placed in the neutral chamber with access to all chambers for 15 min. Time spent in each chamber was analyzed to verify absence of preconditioning chamber preference. For all CPP groups, animals were removed from the study if they spent more than 720 s or less than 180 s in a single chamber (about 8% of rats tested) as previously reported [23] .
Single trial conditioning occurred the following day. To determine if systemic lidocaine produced CPP, chamber pairing occurring 30 min following saline or drug administration to coincide with peak anti-hypersensitivity effects of systemic lidocaine.
Rats first received systemic saline and were placed back into their homecages for 30 min. The rats were then confined to the appropriate pairing chamber for 30 min followed by return to their home cages for 4 h. Rats then received systemic lidocaine (10 mg/kg,s c.) and were placed in their homecages for 30 min. They were then confined to the opposite pairing chamber for 30 min and returned to the housing facility overnight.
To determine if RVM lidocaine induced CPP, rats first received RVM microinjection of saline (0.5 l over 1 min) and were immediately placed in the appropriate pairing chamber for 30 min. Four hours later, rats received RVM microinjection of lidocaine (4%w/v in 5 l over 1 min) and were immediately placed in the opposite pairing chamber for 30 min.
In both protocols, all drug pairings occurred in the afternoon to prevent potential effects of drug administration during the morning session from interfering with the afternoon pairing as previously described [24, 16, 25] .
On test day, 24 h later, rats were placed in the CPP box for 15 min and time spent in each chamber was analyzed. Difference scores were calculated by subtracting the post-conditioning time from the pre-conditioning time spent in the drug paired chamber. A positive score reflects increased post-conditioning time spent in the drug pair chamber compared to preconditioning time indicating CPP.
RVM injection verification
To verify RVM injections, 0.5 l toluidine blue ink was injected bilaterally into the RVM across 1 min. The brains were removed and post-fixed in a 10% formaldehyde solution followed by immersion in 20% sucrose solution for cryoprotection. Brains were cut serially at 40 m thick coronal sections and slices analyzed using an optic microscope to verify the correct position of the cannula. Only animals with correct cannula placements were included in the data analysis [26] .
Statistical analysis
Lidocaine effects on thermal and mechanical hypersensitivity were analyzed using two-way repeated measures analysis of variance (ANOVA) followed by post hoc analysis with the Newman Keuls post-hoc test. For CPP experiments, data were analyzed by 2-factor ANOVA (chambers vs treatment) followed by the Bonferroni test of post-conditioning compared to preconditioning time spent in the drug-paired chamber. Difference scores for the drug paired chamber were used to determine group differences between nerve injured and sham operated rats using paired t-tests. In all statistical analysis, p values less than 0.05 were considered significant.
Results
Systemic lidocaine blocks evoked hypersensitivity but does not induce CPP
On day 5, CCI-ION reduced the latency to heat-evoked responses compared to sham-operated rats. Systemic lidocaine (10 mg/kg,s c.) reversed CCI-ION-induced heat hypersensitivity, with peak effect observed 60 through 120 min after administration (Fig. 1a , *p < 0.05 vs CCI-ION saline). On day 15 after CCI-ION, a significant reduction on the facial mechanical threshold was detected in about 50% of the rats, but the remaining did not develop tactile hypersensitivity (data not shown). Systemic lidocaine (10 mg/kg,s c.) reversed the facial tactile hypersensitivity with peak effects observed 30-60 min post administration (Fig. 1b, * (Fig. 1d, p > 0 .05 vs null hypothesis of 0). It is noteworthy that systemic treatment with lidocaine did not impair locomotion as assessed in the open field test (data not shown).
RVM lidocaine attenuates tactile hypersensitivity and induces CPP but does not block CCI-ION-induced heat hypersensitivity
On day 5, RVM lidocaine (4%, 0.5 l) did not alter CCI-ION induced heat hypersensitivity (Fig. 2a) . On day 15, CCI-ION-induced tactile hypersensitivity was attenuated by the RVM lidocaine, with peak effect observed 30 and 60 min post-RVM injection (Fig. 2b , *p < 0.05 vs CCI-ION saline). On day 5, RVM lidocaine failed to induce CPP in CCI-ION-or sham-treated rats (Fig. 2c, p > 0 .05 vs null hypothesis of 0). Only data from animals with verified accurate injections were included (58/97 total rats, 59.8%), as represented in the map (Fig. 2c inset, closed circles indicate hits, open circles indicate misses). On day 15, rats with CCI-ION-induced facial tactile hypersensitivity demonstrated a significant increase in the time spent in the lidocaine-paired chamber (Fig. 2d, *p < 0.05 vs sham) . In contrast, RVM lidocaine injections failed to induce CPP in rats that failed to develop tactile hypersensitivity 15 days post-CCI-ION (Fig. 2d , p > 0.05 vs the null hypothesis of 0). Only data from animals with verified accurate injections were included (84/128 total rats, 65.6%), as represented in the map (Fig. 2d inset, closed circles indicate hits, open circles indicate misses). Analysis of data from the RVM misses demonstrated that OFF-site injection of lidocaine failed to reverse heat or tactile hypersensitivity and did not alter the time spent in the lidocaine paired chamber for any treatment group (data not shown).
Discussion
We demonstrate that CCI-ION induces spontaneous pain that is observed 15 days post-surgery as indicated by CPP to a chamber paired with RVM lidocaine administration. These observations indicate that spontaneous pain is mediated by descending facilitatory pain pathways from the RVM. We further demonstrate that RVM lidocaine fails to alter heat hypersensitivity or induce CPP 5 days post-surgery, indicating that descending facilitatory pathways do not mediate the injury-induced pain state at this timepoint. Systemic lidocaine fully reversed thermal hypersensitivity 5 days and attenuated tactile hypersensitivity 15 days post-CCI-ION but failed to induce CPP at either time-point. These data suggest that CCI-ION-induced evoked and spontaneous pain observed 15 days post-CCI-ION are mediated by descending facilitatory pain pathways and that spontaneous pain may show a delayed development, emerging between 5 and 15 days post-injury.
Our observations of thermal hypersensitivity 5 days post-CCI-ION surgery are consistent with clinical observations [27, 5] indicating that decreased mechanical pain hypersensitivity and heat pain threshold represent the most prominent QST abnormalities detected in TN patients. Other preclinical studies have demonstrating that CCI-ION-induced heat hypersensitivity is observed ipsilateral to the CCI-ION, emerges during the first week post-injury, and lasts approximately 2-3 weeks [6, 7, 9, 21] . These observations indicate that CCI-ION heat hypersensitivity may reflect peripheral sensitization. Consistent with this, both RTX induced ablation of TRPV1 receptor expressing cells in the trigeminal ganglion and administration of a TRPV1 receptor antagonist block CCI-ION-induced heat hyperalgesia indicating that CCI-IONinduced heat hypersensitivity is dependent on afferent sensory input from TRPV1 expressing trigeminal neurons [28, 29] . Altogether, these data indicate that heat hypersensitivity after CCI-ION is result of peripheral sensitization of TRPV-1 expressing fibers. We note that it is possible that lidocaine may be acting on other central targets as systemic administration of lidocaine has been proposed to work through actions at both the peripheral and central nervous system [30] . Future studies targeting peripheral input (e.g. RTX)
or using other peripherally restricted agents can be used to further strengthen this conclusion. The heat hypersensitivity reported following CCI-ION is consistent with clinical observations reporting heat hyperalgesia in patients with trigeminal neuropathic pain, including TN [31, 5] , although not reported as frequently as mechanical hypersensitivity [27] .
Several reports demonstrate that CCI-ION induces tactile hypersensitivity approximately 10-15 days post-injury [7, 32, 8] and affect both sides of the face [33, 8] , suggesting the development of central sensitization. Descending modulatory pain pathways have been indicated as important mediators of central sensitization across a variety of pain states including nerve injury, osteoarthritis, and cancer pain [10, 11, 23, 16, 34, 15] . We determined whether blocking descending facilitatory pain pathways by lidocaine microinjection into the RVM blocks CCI-ION-induced tactile hypersensitivity. Lidocaine injected into the RVM 15 days post CCI-ION attenuated the tactile hypersensitivity. Clinically mechanical hypersensitivity represents one of the most frequent sensory alterations reported by TN patients and it is observed bilaterally in contrast to reports of unilateral spontaneous pain attacks [5] . Our data indicate that this aspect of TN may be a result of central sensitization and is mediated in part by descending facilitatory pain pathways from the RVM.
Persistent background pain is reported in a significant proportion of TN patients [4, 5] . Therefore, we determined whether pain-relief by lidocaine administration induced CPP as previously reports indicate local or RVM lidocaine induces CPP in chronic pain states [23, 35, 16, 25, 26] . Systemic as well as RVM lidocaine failed to produced CPP during the early period of CCI-ION-induced thermal hypersensitivity (i.e. day 5). These results suggest that CCI-ION did not result in persistent ongoing pain at this specific time point. However, future studies examining ongoing pain at earlier time-points post-surgery are indicated. Preclinical studies indicate a robust increase in a subtype of facial grooming represented by medium ipsilateral stroking of the face, potentially reflecting spontaneous pain [8] . Notably, this grooming behavior is observed within 3 days of CCI-ION injury and decreased across the subsequent 2-week period [8] . This grooming reflects a recuperative behavior that diminishes across time due to adaptation to the chronic pain state. Indeed, others have proposed that suppression of nocifensive behaviors indicative of weakness in rodent models of chronic pain is due to the fact that mice and rats are animals of prey [36, 13] .
Our data demonstrate that injection of lidocaine into the RVM attenuates CCI-ION-induced tactile hypersensitivity and blocks ongoing pain observed 15 days post-surgery. These observations are consistent with other studies demonstrating that RVM lidocaine fails to block thermal or tactile hypersensitivity 3 days post-spinal nerve ligation (SNL), but was effective when administered 10 days [12] as well as at time-points at which SNL-induced heat hypersensitivity had resolved, such as 60 days post-injury [17] . These observations suggest that descending facilitatory pain pathways from the RVM are integral to maintenance of chronic neuropathic pain [11, 12, 24, 37, 14, 16, 15, 17] . Specific to the trigeminal system, RVM inactivation attenuated CFA-induced masseter hyperalgesia and contralateral orofacial hyperalgesia induced by microinjection of interleukin-1␤ into the interpolaris/caudalis of rats [38, 39] . More recently, it was demonstrated that bupivacaine injection into the RVM completely blocked dural inflammation-induced facial mechanical allodynia [40] . Together with our observations, these reports indicate that descending facilitatory pain pathways from the RVM maintain both hypersensitivity and spontaneous aspects of chronic trigeminal pain. Future studies are required to determine whether descending facilitatory pain pathways from the RVM maintain spontaneous pain earlier than 15 days post-injury at later time-points post CCI-ION as described in the SNL model of pain [17] to get a more complete understanding of the time-course in which descending facilitatory pain pathways mediate nerve-injury induced trigeminal pain.
In conclusion, the present observations indicate that early sensory changes after CCI-ION are unilateral and likely depend on peripheral trigeminal input. The later development of mechanical hypersensitivity and ongoing pain are maintained by descending facilitatory projections from the RVM. Further investigation into the role of central sensitization in the maintenance of ongoing pain in the setting of trigeminal nerve injury may allow detection of novel molecular targets for development of improved therapeutics for pain management in patients with trigeminal neuralgia.
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